Board Decisions

GF/B33/DP08

Approved by the Board on: 01 April 2015

The Board acknowledges its approval of an interim measure for the financing of Hepatitis C virus treatment until the approval of a broader policy on co-infections and co-morbidities of HIV/AIDS, tuberculosis and malaria (GF/B32/DP07).
Based on the recommendations of the Strategy, Investment and Impact Committee, the Board approves the framework for financing co-infections and co-morbidities of HIV/AIDS, tuberculosis and malaria, as set forth in GF/B33/11.
Accordingly, the Board notes this decision point supersedes GF/B32/DP07.

Related Resources
- GF/B33/11 - Policy on Co-Infections and Co-Morbidities
  download in EnglishPolicy on Co-Infections and Co-Morbidities